首页> 外国专利> USE OF DANSHENSU, NOTOGINSENOSIDE R1 OR THEIR COMBINATION IN PREPARATION OF MEDICAMENTS FOR PREVENTING AND TREATING DISEASES CAUSED BY MICROCIRCULATION DISORDER

USE OF DANSHENSU, NOTOGINSENOSIDE R1 OR THEIR COMBINATION IN PREPARATION OF MEDICAMENTS FOR PREVENTING AND TREATING DISEASES CAUSED BY MICROCIRCULATION DISORDER

机译：在预防和治疗微循环障碍所致疾病的药物制备中使用丹参素，三七皂苷R1或其组合

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to a new use of traditional Chinese drug products of Danshensu (DLA), Notoginsenoside R1 (R1) and their combination, in particular to the therapeutic and preventive effects of DLA, R1 and their combination on the diseases caused by microcirculation disorder.

机译：本发明涉及丹参素（DLA），三七皂苷R1（R1）及其组合的新用途，尤其涉及DLA，R1及其组合对微循环障碍引起的疾病的治疗和预防作用。。

著录项

公开/公告号KR20120099453A

专利类型
公开/公告日2012-09-10

原文格式PDF
申请/专利权人 TASLY PHARMACEUTICAL GROUP CO. LTD.;
展开▼

申请/专利号KR20127014477
发明设计人 HAN JINGYAN;GUO JUN;YANG JIYING;SUN KAI;WANG MINGXIA;ZHANG YU;LIU YUYING;
展开▼

申请日2010-11-04
分类号A61K31/704;A61K31/192;A61P1/12;A61P11/06;
国家 KR
入库时间 2022-08-21 17:09:12

相似文献

专利
外文文献
中文文献